Nadège Néant

6PUBLICATIONS
31CO-AUTHORS
PharmacogenomicsFood properties (incl. characteristics and health benefits)Predictive and prognostic markersEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 22, 2026
External Evaluation of Population Pharmacokinetic Models of Cabotegravir, During Its Oral and Intramuscular Administration in HIV-Infected Patients.

|Aug 18, 2025
Therapeutic Drug Monitoring of Long-Acting Cabotegravir and Rilpivirine in a National Cohort of People With HIV-1: First Results From the ANRS-MIE CARLAPOP Study.

Nadège Néant, Minh P Lê, Stéphane Bouchet

|Jan 01, 2024
Enteral administration of crushed rilpivirine in a patient with HIV: A case report.

Gwendoline Ragonnet, Hélène Laroche, Nadège Néant

|Apr 13, 2023
Phase I Study of a Combination of Fluvastatin and Celecoxib in Children with Relapsing/Refractory Low-Grade or High-Grade Glioma (FLUVABREX).

Pierre Leblond, Emmanuelle Tresch-Bruneel, Alicia Probst

|May 07, 2020
Usefulness of therapeutic drug monitoring of rilpivirine and its relationship with virologic response and resistance in a cohort of naive and pretreated HIV-infected patients.

Nadège Néant, Minh Patrick Lê, Naïm Bouazza

|Jan 28, 2018
Population pharmacokinetics of Rilpivirine in HIV-1-infected patients treated with the single-tablet regimen rilpivirine/tenofovir/emtricitabine.

Nadège Néant, Florence Gattacceca, Minh Patrick Lê

Pageof 1

Frequent Collaborators

4 joint publications

Caroline Solas

3 joint publications

Minh Patrick Lê

3 joint publications

Gilles Peytavin

2 joint publications

Florian Lemaitre